Filter
785
Filtered Results: 785
Text search:
serologic
surveillance
Featured
Recommendations
89
New Publications
222
Language
Document type
No document type
414
Guidelines
171
Studies & Reports
97
Manuals
36
Fact sheets
26
Strategic & Response Plan
25
Situation Updates
9
Infographics
4
Training Material
2
Resource Platforms
1
Countries / Regions
India
39
Global
32
Latin America and the Carribbean
22
Africa
20
Nigeria
19
Congo, Democratic Republic of
16
Ethiopia
16
Philippines
15
South Africa
15
Bangladesh
14
Brazil
13
Western and Central Europe
11
Nepal
10
Sierra Leone
10
Tanzania
10
Senegal
9
Zambia
9
West and Central Africa
8
East and Southern Africa
8
Kenya
7
Uganda
7
Rwanda
6
Burkina Faso
6
Germany
6
Russia
6
Central African Republic
6
Haiti
5
Asia
5
Venezuela
5
Eastern Europe
5
Angola
5
Colombia
4
Cameroon
4
Syria
4
Malawi
4
Mozambique
4
Middle East and North Africa
4
South–East Asia Region
4
Namibia
4
Liberia
4
Madagascar
4
Ukraine
3
Lesotho
3
Ghana
3
Benin
3
Afghanistan
3
USA
3
Pakistan
3
North Macedonia
2
China
2
Iran
2
Guinea
2
Cambodia
2
Jordan
2
Saudi Arabia
2
Eastern Europe and Central Asia
2
Paraguay
2
France
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Lebanon
2
Sudan
2
Chad
2
Botswana
2
South Sudan
2
Iraq
2
Tajikistan
1
Mexico
1
Turkey
1
Australia
1
Togo
1
Albania
1
Laos
1
Peru
1
Zimbabwe
1
Morocco
1
Qatar
1
Italy
1
Western Pacific Region
1
Tunisia
1
Portugal
1
Southern Africa
1
Argentina
1
Vietnam
1
Sri Lanka
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Libya
1
Bhutan
1
Indonesia
1
Somalia
1
Ecuador
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
86
Guidelines
75
Studies & Reports
45
Policies
44
COVID-19
41
HIV & STI
19
Hepatitis
18
Vaccine-preventable Diseases
18
General Guidelines
16
Statistics
16
Virology
15
Disease Prevention & Control
15
Pediatrics
10
Capacity Building
10
NTDs & Others
10
Chagas
8
Yellow Fever
7
Drugs & Medical Equipment
7
Women & Child Health
7
Leishmaniasis
7
TB
7
Communicable Diseases
6
Paediatrics
6
Rabies
6
Diarrhoeal Disease/Cholera
6
Quality Control & Assurance
6
Dengue
6
Infection Control & Prevention (IPC)
5
Yersinia pestis (Plague)
5
Countries
5
Hematology
4
Vector Control
4
MPOX - Monkeypox
4
Humanitarian Crisis
4
Yaws
3
Monitoring & Evaluation
3
Hemorrhagic Fever
3
Clinical Guidelines
3
Demograhic Health Surveys DHS
3
Information, Education and Communication (IEC)
3
Immunization
3
General Guidelines
3
Health Systems
3
Parasitology
3
Non-communicable Diseases
3
Neonatal Care
3
Malaria
3
Public Health
2
Bacteriology
2
Taeniasis/ Cysticercosis
2
Schistosomiasis
2
Health System Strengthening
2
Medical Devices & Equipment
2
Disabilities
2
Other
2
Respiratory Infections
2
Communicable Diseases
2
Gynaecology & Obstetrics
2
Maternal Health
2
Human African Trypanosomiasis
2
Zika
1
Pharmacy & Technology
1
Child Health
1
Disaster Preparedness
1
Onchocerciasis
1
Humanitarian Aid
1
Sex. & Repr. Rights
1
NCD
1
Community Health
1
Needs Assessment
1
Leprosy
1
Women & Child Health
1
Primary Health Care
1
Laboratory Quality Assurance
1
Key Resources
1
Reproductive Health
1
Toolboxes
Country specific documents
31
Diagnostics & Laboratory Guidance
27
Surveillance
24
Reports & Studies
18
Clinical Guidelines
14
Surveillance & Contact tracing
14
Public Health
12
Prevention & Preparedness
11
Influenza Prevention & Control
10
Latin America & the Carribean
10
Clinical Aspects
9
Context & Facts
8
Infection Control General
8
Clinical Aspects & Diagnostics
8
Studies & Reports
8
Gynaecology / Obstetrics
7
Assessment & Studies
7
HIV testing & services
7
Paediatrics
7
Chagas
7
Studies & Reports
7
HIV in Key Populations
7
Preparedness & Prevention
7
Treatment & Prevention
6
Hepatitis
6
Treatment Guidelines HIV
6
Treatment Guidelines
6
Context & Facts, Travel Advice
6
Clinical Aspects & Diagnostics
6
Overview, Studies & Reports
6
Antiretroviral Treatment ART
6
Eastern Europe and central Asia
6
Plague Prevention & Control
6
Laboratory Guidance
5
Yellow Fever Prevention & Control
5
Children & Adolescents
5
Opportunistic Infections
5
Laboratory
5
Leptospirosis
5
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
5
Asia and Pacific
5
Co-Morbidities (except TB)
5
Dengue Prevention & Control
5
Chikungunya Prevention & Control
5
Zika Prevention & Control
5
HIV service delivery
5
Paediatrics
5
Laboratory & Diagnostics
5
ART Drug Resistance
4
Ebola Prevention & Control
4
Clinical Aspects, Treatment & Prevention
4
Yellow Fever
4
HIV surveillance
4
HIV
4
Infection Prevention & Hygiene
4
For Pregnant Women
4
Training, others
4
Global Impact: Socio-economic, health services, TB & HIV
4
Immunization Guidelines
4
Long COVID/ Post-COVID Syndrome
4
Biontech/Pfizer Comirnaty
4
Rational use of Medicine
4
Zoonoses
4
MPOX - Monkeypox
4
MPOX - Monkeypox
4
Clinical Aspects & Diagnostics
4
Detection & Diagnosis
4
Prevention of mother-to-child transmission (PMTCT)
4
Testing Guidelines
4
Action Plans, Policies & Response
4
Situation Reports, others
4
Preparedness & Prevention
4
Country specific
3
Adults
3
Influenza
3
Surveillance
3
Vaccination
3
Laboratory & Sampling
3
General
3
Clinical Guidelines
3
Appeals and Response Plans
3
Gender Aspects
3
Hospital Readiness/Essential Health Services
3
Genomic sequencing
3
One Health
3
General Guidelines for Rational Use
3
Infectious Diseases
3
Clinical Aspects & Diagnostics
3
Statistics & Facts
3
Studies & Reports
3
Yaws & other Endemic Treponematoses
3
Access to treatment and laboratory
3
General
3
Research & Access
3
Travel Medicine
3
Public Health
3
Rapid Response
2
Health Systems
2
Treatment Guidelines
2
Childhood TB
2
IPC
2
Vaccines & Immunization
2
Key Resources
2
Prevention Guidelines
2
Substance Use Disorders, Others
2
Dengue
2
Policies
2
Transgender People
2
Men who have sex with men (MSM)
2
Training Material
2
Ebola
2
Children
2
Microcephaly
2
Supporting tools
2
For General Public & Community
2
For Parents & Children
2
Access & Strategy
2
TB/HIV
2
SARS-CoV-2 Variants
2
Vaxzevria (Astra Zeneca)
2
Research & Pipeline
2
Inactivated COVID-19 Vaccines
2
Colombia
2
Essential Medicines
2
Pediatrics
2
General documents One Health
2
Public Health
2
Prevention & Measures
2
Health Impact & Climate Change
2
MPOX -Monkeybox Prevention & Control
2
Leishmaniasis
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Statistics & Facts
2
Studies & Reports
2
Studies & Reports
2
Studies & Reports
2
NTDs General
2
Vector control
2
Echinocccosis
2
Onchocerciasis
2
Clinical Guidelines
2
Substance Use Disorders & Addiction
2
National Emergency Response Plans
2
TB & Prisoners
2
Roadmaps, Action Plans & Policies
2
Situation Reports
2
HIV and coinfection
2
TB/HIV Coinfection
2
Western & Central Europe
2
South-east Asia Region
2
Reports & Studies Children HIV
2
Infection Control
2
Kenya
2
Prisoners
2
Outbreak Prevention & Control
1
Behaviour Change/Life Skill Education
1
Policies & Strategies
1
Meningitis Prevention & Control
1
Clinical Guidelines
1
Plague Situation Reports
1
Europe
1
For General Public
1
Policies & Strategies
1
Clinical Guidelines
1
Vector Control
1
Vaccination
1
Pediatrics
1
Plague
1
Schizophrenia
1
Context, Facts & Travel Advice
1
Infection Control
1
Platforms and initiatives
1
Drug resistance
1
Eastern Europe
1
Others
1
TB
1
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
1
Cholera Prevention & Control
1
Children/Adolescents Mental Disorders
1
Prophylaxis
1
Research
1
Mozambique
1
Health & Refugee
1
Public Health
1
Country Guidelines
1
Information for different audiences
1
Manual & Leaflet
1
HIV / AIDS
1
Sustainable Development Goals
1
Russia
1
Sex Worker
1
International
1
DR Congo
1
Climate & Health
1
Clinical Guidelines
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Health Personnel
1
COVID-19
1
Clinical Aspects
1
PPE Personel Protective Equipment
1
Poster & Infographics
1
COVID-19
1
Country Specific
1
For Migrants & Refugees
1
Simulations
1
Prison & Detention
1
Human Rights
1
Scientific & Research Studies
1
Educational Settings
1
Workplace
1
Physical Distancing
1
HIV and COVID-19
1
COVID-19
1
Medical & Community Masks
1
Oxygen Therapy
1
Blood Supply
1
Situation Reports COVID-19
1
RCCE Guides & Manuals
1
Vaccine Candidates & Research
1
Non-pharmaceutical interventions (NPIs)
1
Long-term Care Facilities
1
Presentation
1
Logistics & Supply
1
TB/COVID-19
1
Moderna
1
Johnson & Johnson
1
Covaxin
1
Others
1
Handbooks & Manuals
1
Midwives
1
Nurses
1
Booster Doses
1
Essential Medicines & Devices Lists
1
Quality Assurance
1
HIV &TB
1
Women & Maternal Health
1
Pharmaceutical Dosage Forms
1
Pharmacovigilance
1
Situation Reports & Updates
1
Guidelines & Manuals
1
Health Care In Conflict Settings
1
Best Practice Examples
1
NTDs
1
Strategies & Roadmaps
1
Capacity Building & Resources
1
Capacity Building & Resources
1
Capacity Building & Resources
1
Statistics & Facts
1
Statistics & Facts
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Policies & Strategies
1
Prevention & Control
1
Health Worker
1
Women
1
Studies & Reports
1
Diagnosis
1
Training Material
1
Botswana
1
General
1
Neurological Disorders
1
Contact Tracing
1
Zika
1
General Aspects
1
Assessment & Response
1
Disease Prevention & Control
1
TB/HIV Global
1
Prophylactic Treatment
1
Diarrhoea
1
Training
1
Germany
1
Uganda
1
Clinical Guidelines
1
Assessment
1
Yellow Fever Situation Report
1
TB
1
Laboratory
1
Marburg Virus Situation Reports
1
Epidemiology
1
Eastern Europe & Central Asia
1
Chikungunya
1
Case Definitions
1
Pregnant women
1
Meningitis & Encephalitis
1
Situation Reports & Updates
1
Eastern and Southern Africa
1
Neurological disorders, Others
1
Treatment & Clinical Management
1
En el presente documento se comunica el progreso logrado en la Región hacia la eliminación de la transmisión maternoinfantil del VIH y la sífilis entre los años 2010 y 2017. Se trata también del primer informe regional sobre la eliminación de la transmisión maternoinfantil y durante la prime...
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 29 JULY 2016, 91th YEAR / 29 JUILLET 2016, 91e ANNÉENo 30, 2016, 91, 349–364
Autres troubles
Chapitre H.5
Edition en français Traduction : Bojan Mirkovic Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’...
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
PLOS One November 20, 2020 https://doi.org/10.1371/journal.pone.0241799 . The first autochthonous case of chikungunya virus (CHIKV) infection in Brazil was in September 2014 in the State of Amapá, and from there it rapidly spread across the country. The present study was conducted in 2016 in the st...
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector...
he road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators prese...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
Epidemiological Update
Dengue
7 February 2020
Situation summary
In the Region of the Americas, between epidemiological week (EW) 1 and EW 521 of 2019, a total of 3,139,335 cases of dengue have been reported (321.58 cases per 100,000 population), including 1,538 deaths. Of the total cases, 1,367,...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
La schistosomiase humaine est une maladie parasitaire chronique et aigüe causée par une infection par des douves du sang (vers trématodes) du genre Schistosoma. Cette maladie est un problème de santé publique dans les zones tropicales et
subtropicales d’Afrique, d’Asie, des Caraïbes et d...
